国内jiujiu,情色视频在线观看高清

COVID-19 Vaccine Sales in 2025 Pfizer In 2025, COVID-19 vaccines still generate over $1 billion in sales. Explore surprising growth trends for Novavax and Pfizer, market declines, and shifting U.S. policies under the Trump administration and HHS Secretary Robert F. Kennedy Jr.
Pfizer's Q1 2025 Financial report Market Trend Pfizer's Q1 2025 earnings report highlights strong adjusted EPS growth despite revenue decline. Key drivers include Comirnaty and Vyndaqel, with cost savings and R&D efficiency boosting performance.
Global Biopharma Layoffs April 2025 Layoffs Stay updated on recent global biopharma layoffs in April 2025. Learn about job cuts, restructuring plans, and the latest industry developments across leading biotech and pharma companies.
2024 Global Top 10 Pharmaceutical Companies Market Trend The 2024 global ranking of the top 10 pharmaceutical companies showcases the continued strength of industry leaders like Johnson & Johnson, Roche, and Merck. Pfizer, AstraZeneca, and Eli Lilly also maintain strong positions with impressive growth and strategic investments.
The Global Vaccine Market: How Pfizer, Merck, GSK & Sanofi Maintain Their Dominance Market Trend As the pandemic subsides, the industry is returning to pre-pandemic dynamics, with Pfizer strengthening its pneumonia vaccine leadership, Merck betting on HPV and RSV, GSK focusing on meningitis, and Sanofi expanding its RSV monoclonal antibody business.
Top 10 Global Pharmaceutical Giants in Autoimmune Business in 2024 Autoimmune The autoimmune sector saw explosive growth in 2024, with mergers and acquisitions skyrocketing by 150%. Giants like AbbVie, J&J, and Eli Lilly are reshaping the landscape. Explore the Top 10 revenue rankings in the autoimmune business and future trends.
Pharmaceutical Giants Ranking 2024 Market Trend Explore the top pharmaceutical giants of 2024, including Merck, Johnson & Johnson, and more. Learn about their revenue, profits, R&D investments, and market value in this detailed ranking report.
Pfizer 2024 Financial Report Financial statements Pfizer's 2024 financial report highlights a 7% revenue increase, with strong performance from oncology, migraine drugs, and ADCs. The company also expects significant advancements in 2025 across various therapeutic areas.
Pfizer CEO: All-in on Weight Loss Drug Development Pfizer Pfizer CEO Albert Bourla focuses on advancing weight loss drug development, with new small molecule GLP-1 treatments and cancer therapies. The company aims to tackle challenges in a rapidly growing market.
Big Pharma -Waiting for the other Shoe to Drop Biotech Explore the shifting landscape of big pharma as clinical trial results, patent cliffs, and innovative therapies shape 2025. Discover how giants like Eli Lilly, Pfizer, and Novo Nordisk navigate challenges and opportunities in weight loss, oncology, and vaccines.

< Pre 123 Next >

Articles Archives

Hot Articles

All Categories

Agri & Industry Cosmetic Laboratory Pharmaceutical Food

国产91视频久久,亚洲综合色图在线观看,五月天操逼网,日韩色色AV,青青在线A片,亚洲最大色在线观看,欧美熟妇丝袜诱惑,青青操逼视频,日韩无码操出水